Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections

Journal of Infectious Diseases

Volumn 183, Issue 12, 2001, Pages 1767-1774

  Roy Burman, Arup ^a,b   Savel, Richard H ^a   Racine, Sara ^c   Swanson, Britta L ^a   Revadigar, Neelambika S ^a   Fujimoto, Junichi ^a   Sawa, Teiji ^a   Frank, Dara W ^c   Wiener Kronish, Jeanine P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETORY PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BLOOD CULTURE; CHILD; CONTROLLED STUDY; CRITICAL ILLNESS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOBLOTTING; INFANT; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; RISK FACTOR; VIRULENCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; FEMALE; HUMANS; IMMUNOBLOTTING; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 0035877065     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320737     Document Type: Article

References (32)

1. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System
2. Nosocomial infections in pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System
3. Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies
4. Histology and microbiology of ventilator-associated pneumonias
5. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
6. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection
7. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin
8. Lung infections. III. Pseudomonas aeruginosa and other related species
9. Type III secretion systems: Machines to deliver bacterial proteins into eukaryotic cells?
10. Type III protein secretion systems in bacterial pathogens of animals and plants
11. Type III secretion machines: Bacterial devices for protein delivery into host cells
12. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
13. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
14. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon
15. The exoenzyme S regulon of Pseudomonas aeruginosa
16. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
17. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S
18. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation
19. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD
20. Virulence role of V antigen of Yersinia pestis at the bacterial surface
21. Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa
22. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections
23. Estimability and estimation in case-referent studies
24. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa
25. Genetic relationship between the 53 and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa
26. Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: Variations in virulence factors and virulence genes
27. Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus
28. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates
29. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis
30. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis
31. The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients
32. Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients